About
SpliSense Ltd., is a growing and exciting biotechnology company, developing novel therapies for genetic diseases by inhalation. The company is currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients.
Tags
Total Employees
17
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
54Traction
50Team
30Visibility
20Profile
70Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does SpliSense do?
SpliSense Ltd., is a growing and exciting biotechnology company, developing novel therapies for genetic diseases by inhalation. The company is currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients.
How much funding has SpliSense raised?
SpliSense has raised a total of $29M in funding. The most recent round on record is Series B.
When was SpliSense founded?
SpliSense was founded in 2017.
What industry does SpliSense operate in?
SpliSense operates in Healthcare, Lung, Treatment, Biotech, Cystic Fibrosis, mRNA.
How many employees does SpliSense have?
SpliSense has approximately 17 people on record.